Clinical Trial Update: A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an experimental drug in women with breast cancer and metastatic bone disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Disease
• Breast Cancer

Drugs mentioned

• Experimental drug

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Cancer, Metastatic Bone Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-02-01